Clinical trial · Observational
UNC Metastatic Cancer Radiation Therapy Registry
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this registry is to collect clinical data from participants attending UNC Hospitals who present with metastatic cancer and are evaluated to receive radiation therapy as part of their standard of care treatment. The goal of this study is to provide a foundation for studies designed to identify projects across the translational continuum related to metastatic cancer and radiation therapy treatment. The relevant clinical data will be linked to patient-reported outcomes (PROs) thus allowing for a unique and robust dataset. Ultimately, this registry will provide current and future studies with the ability to analyze the correlation of radiation therapy regimens with metastatic cancer outcomes.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Metastatic Cancer | Malignant Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Radiation therapy | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Palliative radiation therapy
- description
- Subjects who are with metastatic cancer receive palliative radiation therapy.
- interventionNames
- Radiation: Radiation therapy
Primary outcomes (1)
- measure
- Clinical Data
- timeFrame
- Up to 1 month
- description
- Clinical data and radiological assessments from participants with metastatic cancer receiving radiation therapy as a part of the standard of care will be collected.
Secondary outcomes (1)
- measure
- Patient reported outcomes (PRO)
- timeFrame
- Baseline, 1 month, 3 months, 6 months, 9 months, and 12 months
- description
- Patient reported outcomes (PRO) from participants will be collected at different time points.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Written informed consent was obtained to participate in the study and HIPAA Authorization for release of personal health information. Ability to understand and willingness to sign informed consent Diagnosed with or is suspected to have metastatic cancer. Age ≥ 18 years at the time of consent. Evaluated to receive radiation therapy as part of their standard-of-care treatment plan. Exclusion Criteria: All participants must not meet any of the following exclusion criteria prior to enrollment to participate in this study: Any serious medical or psychiatric disorder that would interfere with the participant's ability to give informed consent.
References
Publications (0)
Data not yet available